Longfei Wang is a Professor at the School of Pharmaceutical Sciences, Faculty of Medical Sciences, Wuhan University, Wuhan, China. He graduated with a B.S. in Biotechnology from Huazhong Agricultural University in 2005 and obtained his Ph.D. in Biochemistry and Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences in 2011. After graduation, he worked as a postdoctoral research fellow at the Harvard Medical School from October 2011 to April 2017. Subsequently, he worked as a lecturer at the Boston Children's Hospital, Harvard Medical School from April 2017 to July 2021. His research interests lie in the areas of molecular immunology and structural pharmacology. His research topics include elucidating the molecular mechanism of host cell defense against pathogens, investigating the structural basis of signaling in immune cell surface receptors and developing small molecules and biomolecules (antibodies, peptides, nucleic acids, etc.) that can be used to regulate immune signaling pathways. He has authored/co-authored more than 20 publications in international peer-reviewed journals and holds an international patent.
Longfei Wang is a Professor at the School of Pharmaceutical Sciences, Faculty of Medical Sciences, Wuhan University, Wuhan, China. He graduated with a B.S. in Biotechnology from Huazhong Agricultural University in 2005 and obtained his Ph.D. in Biochemistry and Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences in 2011. After graduation, he worked as a postdoctoral research fellow at the Harvard Medical School from October 2011 to April 2017. Subsequently, he worked as a lecturer at the Boston Children's Hospital, Harvard Medical School from April 2017 to July 2021. His research interests lie in the areas of molecular immunology and structural pharmacology. His research topics include elucidating the molecular mechanism of host cell defense against pathogens, investigating the structural basis of signaling in immune cell surface receptors and developing small molecules and biomolecules (antibodies, peptides, nucleic acids, etc.) that can be used to regulate immune signaling pathways. He has authored/co-authored more than 20 publications in international peer-reviewed journals and holds an international patent.